Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
In patients with preexisting cardiovascular disease and overweight or obesity but without diabetes, weekly subcutaneous semaglutide at a dose of 2.4 mg was superior to placebo i...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 1,860
- Institution
- University College London
External Links
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.